FDA's 8 Regulatory Science Priority Areas are described in the Agency's Strategic Plan for Regulatory Science. More information on these 8 Science Priority Areas can be found on the About Science & Research section of FDA's Web site.

FDA is an agency within the Department of Health and Human Services. FDA's organization consists of the Office of the Commissioner and four directorates overseeing the core functions of the Agency: Medical Products and Tobacco, Foods, Global Regulatory Operations and Policy, and Operations. Visit the FDA Organization website for more information.

Modernize Toxicology to Enhance Product Safety: Strategic Plan for Regulatory Science

• Gladys Erives, Ph.D. (Primary) and Luis Jr., Valerio, Ph.D. (Co-preceptor) (Center for Tobacco Products - CTP)
• Nakissa Sadrieh, Ph.D. (Center for Food Safety and Applied Nutrition - CFSAN)

Stimulate Innovation in Clinical Evaluations and Personalized Medicine to Improve Product Development and Patient Outcomes: Strategic Plan for Regulatory Science

• Jeffrey Ballyns, Ph.D. (Center for Devices and Radiological Health - CDRH)
• Ameeta Parekh, Ph.D. (Center for Drug Evaluation and Research - CDER)
• Lynne Yao, M.D. and Lily (Yeruk) Mulugeta, PharmD (Center for Drug Evaluation and Research - CDER)
• Anindita Saha (Center for Devices and Radiological Health - CDRH)
• Peter Tobin, Ph.D. (Stimulate Innovation in Clinical Evaluations and Personalized Medicine to Improve Product Development and Patient Outcomes: Strategic Plan for Regulatory Science) (Center for Devices and Radiological Health - CDRH)

Support New Approaches to Improve Product Manufacturing and Quality: Strategic Plan for Regulatory Science

• Jayaleka Amarasinghe, Ph.D. (The Office of Regulatory Affairs - ORA)
• Celia Cruz, Ph.D. (Center for Drug Evaluation and Research - CDER)
• Benjamin Fisher, Ph.D. and April Marrone, Ph.D. (Center for Devices and Radiological Health - CDRH)
• Thilak Mudalige, Ph.D. (The Office of Regulatory Affairs - ORA)

Ensure FDA Readiness to Evaluate Innovative Emerging Technologies, Strategic Plan for Regulatory Science

• Carolyn Yong, Ph.D. and Steven Oh, Ph.D. (Center for Biologics Evaluation and Research - CBER)
• CAPT Jason Woo, M.D., MPH, FACOG (Center for Drug Evaluation and Research - CDER)

Harness Diverse Data through Information Sciences to Improve Health Outcomes: Strategic Plan for Regulatory Science

• Henry Lau, M.S. (The Office of Regulatory Affairs - ORA)
• Adam Saltman, M.D., Ph.D. (Center for Devices and Radiological Health - CDRH)
• David Spelic, Ph.D. (Center for Devices and Radiological Health - CDRH)